Manipal Health IPO GMP Today

GMP for Manipal Health IPO started at Rs 35 on 24 July 2026 and stood at Rs 25 on 25 July 2026. The downward trend suggests grey market participants are lowering expectations. Watch whether subscription numbers support or contradict this move. GMP typically moves more in the final two to three days before the close date, especially after QIB and HNI bids come in.

Based on today's GMP, Manipal Health IPO listing price estimate is Rs 615.00 per share (issue price Rs 590.00 + GMP Rs 25.00).

Actual listing price will be known on 5 August 2026 when the stock lists on NSE/BSE.

GMP near 4.2% is a weak positive signal. Grey market activity is thin and the listing premium may be limited unless subscription picks up.

GMP has trended lower. Read this together with subscription data before applying.

GMP is unofficial. Listing gain can differ on listing day.

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Manipal Health IPO is -. Compare this with the GMP trend to see if demand aligns.

See live figures on the Manipal Health IPO Subscription Status page.

Manipal Health IPO full details (financials, peers, review).

Incorporated in 2010, Manipal Health Enterprises Limited is one of India's largest multi-specialty healthcare providers. Headquartered locally in Bengaluru, the company operates a massive network of 38 clinical hospitals (48 on a pro forma basis) with over 10,761 licensed beds across the country. It provides advanced tertiary and quaternary care, oncology, cardiology, neurology, and organ transplants. Backed by the legacy of the Manipal Group, the enterprise employs over 24,240 personnel, including top-tier doctors, 11,048 nurses, and 6,362 paramedics, ensuring clinical excellence across both metros and non-metros.